Recruiting Status: Recruiting
Age: 18 – 65 Years Old
STOP-HAE: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema
STOP-HAE: A Phase 3 Study of ADX-324 in HAE (STOP-HAE)
